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Emotional Eating Phenotype is 
Associated with Central Dopamine 
D2 Receptor Binding Independent 
of Body Mass Index
Sarah A. Eisenstein1,2, Allison N. Bischoff1, Danuta M. Gredysa1, Jo Ann V. Antenor-
Dorsey1, Jonathan M. Koller1, Amal Al-Lozi1, Marta Y. Pepino3, Samuel Klein3, 
Joel S. Perlmutter2,4,5,6,7, Stephen M. Moerlein2,8, Kevin J. Black1,2,4,5 & Tamara Hershey1,2,4
PET studies have provided mixed evidence regarding central D2/D3 dopamine receptor binding and 
its relationship with obesity as measured by body mass index (BMI). Other aspects of obesity may be 
more tightly coupled to the dopaminergic system. We characterized obesity-associated behaviors and 
determined if these related to central D2 receptor (D2R) specific binding independent of BMI. Twenty-
two obese and 17 normal-weight participants completed eating- and reward-related questionnaires 
and underwent PET scans using the D2R-selective and nondisplaceable radioligand (N-[11C]methyl)
benperidol. Questionnaires were grouped by domain (eating related to emotion, eating related 
to reward, non-eating behavior motivated by reward or sensitivity to punishment). Normalized, 
summed scores for each domain were compared between obese and normal-weight groups and 
correlated with striatal and midbrain D2R binding. Compared to normal-weight individuals, the 
obese group self-reported higher rates of eating related to both emotion and reward (p < 0.001), 
greater sensitivity to punishment (p = 0.06), and lower non-food reward behavior (p < 0.01). Across 
normal-weight and obese participants, self-reported emotional eating and non-food reward behavior 
positively correlated with striatal (p < 0.05) and midbrain (p < 0.05) D2R binding, respectively. In 
conclusion, an emotional eating phenotype may reflect altered central D2R function better than 
other commonly used obesity-related measures such as BMI.
Reward-related behavioral and neurocircuitry dysfunction may contribute to obesity1 and provide ther-
apeutic targets for prevention and treatment of the disease. However, the role of striatal dopamine (DA) 
signaling in human obesity remains unclear due to mixed results of PET/SPECT studies that assess 
the relationship between body mass index (BMI) and D2/D3 DA receptor (D2/D3R) availability. Some 
studies have found that striatal D2/D3R availability is lower in obesity and negatively correlates with 
BMI2–4 while others find no difference5–7 or higher D2/D3R availability in obese versus normal weight 
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individuals8 or with increasing BMI9. Using a highly specific and non-displaceable ligand, we found no 
significant associations of D2 receptor subtype (D2R) binding with obesity or BMI10.
Differences in human obesity DA PET study findings may be due to several factors. For instance, 
the study samples used have had different degrees of obesity, ranging from overweight (BMI 25.0-29.9 
kg/m2)3,6,9 and mild Class I (BMI 30.0-34.9 kg/m2)3 obesity to more severe Class III (BMI ≥ 40.0 kg/
m2)2,4,5,8–10 obesity. Obesity phenotype and DA signaling abnormalities may differ across classes of obe-
sity1,6. To further complicate interpretation, most of these studies employed radioligands with important 
limitations. Specifically, [11C]raclopride and [18F]fallypride do not distinguish between D2R and D3R11, 
which are localized differently across the brain and may be functionally distinct12. Furthermore, these 
radioligands are displaceable by DA, so D2/D3R availability measures are influenced by endogenous DA 
release as well as by D2/D3R binding per se13–15.
Although BMI is not consistently correlated with D2/D3R availability16, behavioral aspects of obesity 
may have a closer relationship to DA signaling. To address this issue and the limitations described above, 
we assessed obesity-associated characteristics that may relate to DA signaling, such as emotion- and 
reward-based eating and behavior motivated by non-food reward and sensitivity to punishment, in obese 
and normal weight participants. We investigated whether these characteristics correlated with striatal 
D2R using (N-[11C]methyl)benperidol ([11C]NMB), a PET radioligand DA D2 receptor antagonist that 
is highly selective for D2R over D3R17 and other G-protein receptors and is not displaced by endogenous 
DA release18. In addition, since novelty seeking behavior is associated with midbrain D2/D3R binding19, 
we explored the relationship between midbrain D2R binding and obesity-associated behavior.
Methods
Participants. Participants included 17 normal-weight and 22 obese individuals (see Table  1). One 
individual in the normal-weight group was slightly overweight (BMI = 25.9 kg/m2) but percent body fat 
and other weight parameters met normal-weight criteria. Selected data from 15 participants from each 
group were reported previously10. After an overnight fast (at least 8 hr), participants underwent com-
prehensive medical evaluation, routine blood tests, hemoglobin A1C, and an oral glucose tolerance test 
(OGTT). Individuals with self-reported history of diabetes, A1C ≥ 6.5%, or OGTT results that indicated 
impaired fasting glucose, impaired oral glucose tolerance, or diabetes were excluded. Individuals were 
also screened and excluded for IQ < 8020 (WASI), and conditions including parkinsonism, lifetime psy-
chosis, mania, substance dependence, major depression, social phobia, eating disorders (including binge 
eating disorder) and panic disorder by neurological examination and psychiatric interview (Structured 
Clinical Interview for DSM-IV21). Current smoking and medications related to DA function were also 
exclusionary. No participant had smoked tobacco during the past 11 mos. or used medications related to 
DA function during the past month. All participants provided written informed consent. All procedures 
were performed in accordance with the Declaration of Helsinki and approved by Washington University’s 
Human Research Protection Office and Radioactive Drug Research Committee.
Questionnaires. During the day of the OGTT, immediately and 1 hr after which a light snack and 
lunch were provided, respectively, participants completed questionnaires addressing DA-related con-
structs, or domains, of interest: 1) eating behavior related to emotion including avoidance of negative 
affect; 2) eating behavior related to reward including craving for palatable foods and inability to limit 
intake of sweet foods; 3) non-food reward behavior, including approach, sensitivity, motivation, and 
expectancy for non-food reward stimuli; and 4) punishment avoidance including inhibition, sensitivity, 
and expectancy. Self-report questionnaires or subscales of self-report questionnaires were included in 
these different domains (Table  2) based on their descriptions in original manuscripts introducing and 




4 men, 13 women 16 
C, 1 AA
3 men, 19 women 11 C, 
10 AA, 1 Bi*
Mean (SD), range
Age (years) 28.5 (5.5), 21–39 31.4 (6.3), 23–40
Education level (years) 16.6 (1.4), 14–19 15.1 (1.9)*, 12–18
Body Mass Index (kg/m2) 22.1 (2.0), 18.7–25.9 39.6 (5.2)***, 33.4–51
Beck Depression Inventory 
II 3.3 (4.4), 0–15 6.0 (6.1), 0–21
IQ 113.0 (12.7), 87–131a 107.5 (12.3), 84–131
Table 1.  Participant Characteristics C, Caucasian; AA, African American; Bi, Biracial *, p < 0.05, ***, 
p < 0.001 relative to normal-weight group aData not available for 2 participants
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summed together with other measures included in the domain to yield final domain scores for each 
individual.
The following questionnaires were included in the Eating Related to Emotion domain: The Emotional 
Eating Scale22 (EES) assesses urge to eat due to negative emotion. The Dutch Eating Behavior ‘Emotional’ 
subscale23 (DEBQ ES) consists of summed self-ratings of tendencies to eat in response to both ‘diffuse’ 
(e.g., bored) and ‘clearly labeled’ (e.g., anger) emotions. The ‘mood-altering effect’ subscale of the Sweet 
Taste Questionnaire24 (STQ MAE) assesses the degree to which eating sweet foods alters mood in a 
positive manner.
The following questionnaires were included in the Eating Related to Reward domain: The Binge 
Eating Scale25 (BES) assesses the degree to which one experiences binge eating, including behavior (e.g., 
eating in secret) and emotions that occur before and after a binge (e.g. lack of control). The ‘Impaired 
control over eating sweets’ subscale of the STQ24 (STQ IC) is a measure of one’s ability to refrain from 
eating sweets. We used the total score on the Food Craving Inventory26 (FCI) to measure general craving 
for sweet and high-carbohydrate or fatty foods.
The following questionnaires were included in the Non-food Reward domain: The Behavioral 
Activation System (BAS) portion of the BIS/BAS27 questionnaire consists of three subscales: drive, 
fun-seeking and reward responsiveness. It is meant to measure BAS sensitivity. Individuals with stronger 
BAS should be more sensitive and derive more pleasure upon exposure to reward cues28,29. The sen-
sitivity to reward portion of the Sensitivity to Punishment and Sensitivity to Reward Questionnaire30 
(SPSRQ) also assesses BAS functioning. The reward expectancy portion of the Generalized Reward and 
Punishment Expectancy Scales31 measures optimism and expectancy of positive life events. The ‘curi-
osity behavior’, or novelty-seeking, dimension of the Temperament and Character Inventory32 (TCI-R) 
reflects bias towards active novelty-seeking, impulsivity and approach towards reward cues. The ‘reward 
Domain and Included Questionnaires Normal-weight Obese
Eating Related to Emotion − 1.46 (1.86) 1.13 (2.72)**
Emotional Eating Scale total score (EES, Arnow et al., 
1995) 12.53 (13.13) 27.59 (18.95)**
Dutch Eating Behavior Questionnaire Emotional Scale 
average score (DEBQ ES, van Strien et al., 1986) 1.60 (0.57) 2.51 (0.97)**
Sweet Taste Questionnaire Mood Altering Effects (STQ 
MAE, Kampov-Polevoy et al., 2006) total score 17.82 (7.27) 23.82 (6.97) 
†
Eating Related to Reward − 1.83 (1.83) 1.42 (1.90)***
Binge Eating Scale total score (BES, Gormally et al., 1982) 6.00 (4.37) 15.09 (6.70)***
Sweet Taste Questionnaire Impaired Control over Eating 
Sweets (STQ IC) total score 14.47 (5.97) 21.68 (5.45)***
Food Craving Inventory total of averaged scores (FCI, 
White et al., 2002) 7.95 (2.48) 10.28 (2.05)**
Reward 0.82 (2.22) − 0.66 (.2.26)*
Behavioral Activation System (BAS) total score from BIS/
BAS (Carver and White, 1994) 41.71 (4.73) 37.48 (5.76)*
Reward expectancy total score from Generalized Reward 
and Punishment Expectancy Scales (GRAPES, Ball and 
Zuckerman, 1990)
8.71 (2.80) 7.24 (3.38)
Sensitivity to reward total score from Sensitivity to 
Punishment and Reward Questionnaire (SPSRQ, Torrubia 
et al., 2001)
8.53 (3.00) 8.62 (3.58)
Summed curious, reward dependency, and persistence 
scores from Temperament and Character Inventory 
(TCI-R, Cloninger et al., 1994)
43.47 (7.37) 41.57 (5.27)
Punishment − 1.02 (2.46) 0.82 (3.85)†
Behavioral Inhibition System (BIS) total score from BIS/
BAS 19.41 (3.45) 20.91 (4.33)
†
Punishment expectancy total score from GRAPES 6.35 (2.55) 7.43 (2.75)
Sensitivity to punishment total score from SPSRQ 6.76 (4.07) 9.45 (6.68)
Harm avoidance total score from TCI-R 10.76 (4.25) 13.68 (6.38)†
Table 2.  Behavioral Domains. Normal-weight n = 17; Obese n = 21-22. Summed z-scores (S.D.) shown 
for each domain. Average score (S.D.) shown for individual questionnaires. ***, **, *, p ≤ 0.001, 0.01, 0.05 
relative to normal-weight group. †, p = 0.06 relative to normal-weight group.
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dependency’ dimension of the TCI reflects bias towards prosocial behavior and social approval. The 
‘persistence’ dimension of the TCI reflects degree of perseverance despite fatigue and other obstacles.
The following questionnaires were included in the Punishment domain: The Behavioral Inhibition 
System (BIS) portion of the BIS/BAS27 questionnaire measures BIS sensitivity. People with stronger 
BIS sensitivity should be more sensitive to and experience greater anxiety in response to punishment 
cues28,29. The punishment portions of the GRAPES31 and SPSRQ30 assess punishment expectancy and 
sensitivity, respectively. The ‘damage avoidance’ section of the TCI-R32 assesses bias towards behavior 
aimed at avoiding harm.
MRI and PET Acquisition. On a day separate from the day of the OGTT, participants underwent 
MRI and 2 hr PET scans, which took place between 0900 and 1700. Methods for [11C]NMB synthesis, 
MRI and PET scan acquisitions are described previously10. Each participant intravenously received 6.4 – 
18.1 mCi containing <7.3 μ g unlabeled NMB. [11C]NMB purity was ≥96% and specific activity ≥1066 
Ci/mmol (39 TBq/mmol). Since [11C]NMB is not displaceable by endogenous DA18, participants were 
not asked to fast or otherwise modify their food intake on the night before or day of the scans.
ROI-based Analyses. The methods for our ROI-based analyses are described in Eisenstein et al.10,33. 
The neuroimaging software FreeSurfer (http://surfer.nmr.mgh.harvard.edu) was used for segmentation of 
striatal regions34. To limit multiple comparisons, D2R specific binding (BPND) for each ROI was averaged 
across left and right hemispheres. Putamen and caudate D2R BPNDs were averaged to obtain a composite 
dorsal striatal BPND and ventral striatal BPND included average nucleus accumbens D2R BPND. The mid-
brain region was traced on each individual’s MPRAGE as previously described33.
Voxel-based Analyses. We conducted voxel-based analyses to determine whether specific striatal 
or midbrain clusters of D2R binding related to BMI or Eating Related to Emotion, Eating Related to 
Reward, Non-food Reward, and Punishment behavioral domain scores. Images of D2R BPND across the 
brain were generated for each participant and smoothed with a 6 mm full width at half maximum kernel. 
These images were averaged across normal-weight and obese individuals and thresholded at BPND = 0 to 
use as an explicit mask for regions including striatum or subcortical regions only. Positive and negative 
associations between D2R binding and dependent variables were tested at the voxel level using SPM8 
(http://www.fil.ion.ucl.ac.uk/spm).
Primary Statistical Analyses. Much of the data was managed using REDCap electronic data cap-
ture tools hosted by the Biostatistics Division of Washington University School of Medicine35. Group 
demographic variables were compared with Pearson Chi Square, Mann Whitney U, or t-tests. Dorsal and 
ventral striatal BPND were compared with repeated measures ANCOVA covarying for age, ethnicity, and 
education. Midbrain D2R BPND and domain scores were compared between normal-weight and obese 
groups with ANCOVAs covarying for age, ethnicity and education. Significant findings for a behavioral 
domain were followed up with exploratory ANCOVAs of each questionnaire contributing to that domain. 
Separate hierarchical linear regression models with appropriate covariates (age, ethnicity, education level, 
and/or BMI) were used to analyze the ability of each variable of interest to predict striatal or midbrain 
D2R BPND. These analyses also yielded partial correlations describing the unique variance contributed 
by each variable of interest to BPND. For voxelwise analyses, correlations between D2R binding and BMI 
and behavioral domain scores were calculated as Pearson’s r and tested for significance with Student’s 
one-sample t-tests covaried for age, ethnicity, education, and, for behavioral domains, BMI, at each voxel. 
For SPM analyses, p ≤ 0.001, after multiple comparison correction, at voxelwise level was considered 
significant. For all other analyses, significance level was set at α ≤ 0.05.
Results
Participant Characteristics. Normal-weight and obese groups are described in Table 1. We did not 
have complete Non-food Reward and Punishment questionnaire datasets from one obese individual and 
another obese individual did not undergo a PET scan. Therefore, analyzed data sets including these var-
iables consist of 21 obese and 17 normal-weight individuals. One normal-weight participant’s midbrain 
D2R BPND was too low to be quantified by our processing software and analyses including this variable 
included 20 or 21 obese and 16 normal-weight participants.
BMI and Central D2R Specific Binding. As in our previous report on a subset of these individ-
uals10, after covarying for age, ethinicity and education level, obese and normal-weight groups did 
not differ in striatal BPND (normal weight mean total striatal BPND = 10.30, S.D. = 1.17; obese mean 
total striatal BPND = 10.22, S.D. = 1.34; F1,33 = 1.98, p = 0.17). Across both groups, dorsal striatal D2R 
BPND was greater than ventral striatal BPND at a marginally significant level (dorsal mean BPND = 4.09, 
S.D. = 0.52; ventral mean BPND = 2.08, S.D. = 0.29; F1,33 = 3.87, p = 0.06) and there was no significant 
interaction between group and striatal region (F1,33 = 1.98, p = 0.17). Midbrain D2R BPND was not dif-
ferent between normal-weight and obese groups (normal-weight mean BPND = 0.27, S.D = 0.14; obese 
mean BPND = 0.27, S.D. = 0.09; F1,32 = 0.15, p = 0.70).
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Controlling for age, ethnicity and education, BMI did not predict striatal BPND across all partic-
ipants (dorsal R2 change = 0.07. F1,33 = 2.61, p = 0.12; ventral R2 change = 0.00. F1,33 = 0.02, p = 0.90) 
(Fig.  1), or within either group (normal-weight: dorsal R2 change = 0.01; F1,12 = 0.19, p = 0.67, ventral 
R2 change = 0.00. F1,12 = 0.002, p = 0.97; obese: dorsal R2 change = 0.03; F1,16 = 0.62, p = 0.44, ventral 
R2 change = 0.04; F1,16 = 0.99, p = 0.33). Similarly, BMI did not predict midbrain D2R BPND across 
normal-weight and obese participants (R2 change = 0.00. F1,32 = 0.001, p = 0.98) or within either group 
(normal-weight: R2 change = 0.05; F1,11 = 0.55, p = 0.48; obese: R2 change = 0.12; F1,16 = 2.51, p = 0.13).
Obesity-associated Behavior. Table 2 presents group mean (S.D.) summed z-scores for each domain 
and raw scores for each questionnaire.
The obese group had higher mean domain scores on Eating Related to Emotion (F1,34 = 11.62, p < 0.01; 
Fig. 2A) and Eating Related to Reward (F1,34 = 28.47, p < 0.001; Fig. 2B) and a lower mean domain score 
on Non-food Reward (F1,33 = 5.37, p = 0.03; Fig. 2C). Punishment domain scores were higher in obese 
relative to normal-weight at a marginally significant level (F1,33 = 3.69, p = 0.06; Fig. 2D).
Within the Eating Related to Emotion domain, scores on all three questionnaires were correlated 
with each other (0.63 ≤ r39 ≤ 0.80, p < 0.001) and the obese group scored significantly higher than the 
normal-weight group on EES (F1,33 = 6.42, p = 0.02) and DEBQ ES (F1,33 = 4.75, p = 0.04) and margin-
ally significantly higher on STQ MAE (F1,33 = 3.48, p = 0.07). BMI was associated with the summed 
domain score across the entire sample (r39 = 0.46, p < 0.01) but not when examined just within obese 
(r22 = − 0.24, p = 0.29) or normal-weight (r17 = 0.09, p = 0.74).
The z-scores on the three questionnaires included in the Eating Related to Reward domain were cor-
related with each other (r39 = 0.43, p ≤ 0.01). The obese group scored higher on the BES (F1,34 = 19.57, 
p < 0.001), STQ IC (F1,34 = 14.77, p = 0.001) and the FCI (F1,34 = 10.35, p = 0.003). BMI related to 
the summed domain score in the entire sample (r39 = 0.37, p < 0.02) but not within obese (r22 = 0.07, 
p = 0.78) or normal-weight (r17 = − 0.03, p = 0.91).
Within the Non-food Reward domain, the individual questionnaires did not correlate (0.03 ≤ r38 ≤ 0.28, 
p ≥ 0.09). The obese group had a lower mean score than the normal-weight group on the behavio-
ral approach subscale of the BIS/BAS (F1,33 = 6.47, p = 0.02). Groups did not differ significantly on any 
of the other Reward domain scales (SPSRQ: F1,33 = 0.21, p = 0.65; TCI-R: F1,33 = 0.44, p = 0.51) except 
at a marginally significant level on the GRAPES reward expectancy subscale (obese < normal-weight, 
F1,33 = 3.25, p = 0.08). BMI did not correlate significantly with the summed domain score in the entire 
sample (r38 = − 0.11, p = 0.51) or within normal-weight (r17 = 0.39, p = 0.12; Fig. 3A). However, BMI was 
correlated with the reward summed domain score within obese (r21 = 0.54, p = 0.01; Fig. 3B).
Within the Punishment domain, scores on all questionnaires were correlated with each other 
(0.54 ≤ r39 ≤ 0.79, p ≤ 0.001). The obese group tended to score higher on the behavioral inhibi-
tion portion of the BIS/BAS (F1,33 = 3.11, p = 0.09) and the damage avoidance subscale of the TCI-R 
(F1,33 = 3.17, p = 0.08) than the normal-weight group; these differences were marginally significant. 
Obese and normal-weight groups did not differ on the punishment expectancy subscale of the GRAPES 
(F1,33 = 1.10, p = 0.30) or sensitivity to punishment subscale of SPRSQ (F1,33 = 2.30, p = 0.14). BMI did 
Figure 1. BMI and striatal D2R are not significantly correlated across normal-weight (clear circles) and 
obese (filled circles) groups. D2R specific binding was not correlated with BMI in the a, dorsal or b, ventral 
striatum. Data points are standardized residuals of partial correlations after covarying for age, ethnicity and 
education level. BPND, dopamine D2 receptor binding potential.
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not correlate significantly with the summed domain score in the entire sample (r38 = 0.15, p = 0.37) or 
within normal-weight (r17 = 0.21, p = 0.43) or obese (r21 = − 0.35, p = 0.12) groups.
Obesity-associated Behavior and Central D2R BPND. After covarying age, ethnicity, education level, 
and BMI, the Eating Related to Emotion domain score related to dorsal striatal BPND (R2 change = 0.13. 
F1,32 = 7.51, p = 0.01; partial r = 0.44; Fig. 4A) but Eating Related to Reward (R2 change = 0.02. F1,32 = 1.15, 
p = 0.29), Non-food Reward (R2 change = 0.01. F1,31 = 0.31, p = 0.58) and Punishment (R2 change = 0.00. 
F1,31 = 0.06, p = 0.81) domain scores did not. Within the Eating Related to Emotion domain, EES (R2 
change = 0.08. F1,32 = 5.48, p = 0.03, partial r = 0.38), DEBQ ES (R2 change = 0.12. F1,32 = 6.88, p = 0.01, 
partial r = 0.42) and STQ MAE (R2 change = 0.10. F1,32 = 4.48, p = 0.04, partial r = 0.35) scores were 
associated with dorsal striatal BPND .
After covarying age, ethnicity, education level, and BMI, Eating Related to Emotion domain scores (R2 
change = 0.11. F1,32 = 5.18, p = 0.03) related to ventral striatal BPND (Fig. 4B) but Eating Related to Reward 
(R2 change = 0.05. F1,32 = 2.33, p = 0.14), Non-food Reward (R2 change = 0.00. F1,31 = 0.19, p = 0.67) and 
Punishment (R2 change = 0.02. F1,31 = 0.72, p = 0.40) domain scores did not. Within the Eating Related to 
Emotion domain, DEBQ ES (R2 change = 0.10. F1,32 = 4.71, p = 0.04, partial r = 0.36) scores significantly 
correlated with ventral striatal BPND. STQ MAE (R2 change = 0.08. F1,32 = 3.93, p = 0.06; partial r = 0.33) 
and EES (R2 change = 0.07. F1,32 = 3.17, p = 0.09; partial r = 0.33) scores correlated with ventral striatal 
BPND at a marginally significant level.
After covarying age, ethnicity, education level, and BMI, midbrain D2R BPND was related to Eating 
Related to Emotion domain scores (R2 change = 0.10. F1,31 = 4.88, p = 0.04; partial r = 0.37, Fig.  5A). 
Within this domain, higher midbrain D2R BPND significantly related to higher EES (R2 change = 0.14. 
F1,31 = 6.48, p = 0.02; partial r = 0.42) and DEBQ ES (R2 change = 0.09. F1,31 = 4.71, p = 0.04; par-
tial r = 0.36) scores but was not related to STQ MAE (R2 change = 0.03. F1,31 = 1.23, p = 0.28) scores. 
Figure 2. Behaviors thought to be tightly coupled to dopamine signaling differ between normal-weight 
and obese individuals. Obese individuals self-report higher rates of a, emotion- and b, reward-based 
eating behavior, c, lower rates of non-food reward behavior, and d, higher rates of avoidance of punishment 
relative to normal-weight individuals. Data points are standardized residuals of partial correlations after 
controlling for age, ethnicity, and education level. *, **, ***, p ≤ 0.05, 0.01, 0.001 relative to normal-weight. 
For avoidance of punishment, p = 0.06 relative to normal-weight.
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Midbrain D2R BPND was also related to Non-food Reward domain scores (R2 change = 0.13. F1,30 = 4.82, 
p = 0.04; partial r = 0.37, Fig.  5B). Within the Non-food Reward domain, higher midbrain D2R BPND 
related to higher scores on the BAS (R2 change = 0.10. F1,30 = 3.83, p = 0.06; partial r = 0.34) and reward 
sensitivity subscale of the SPSRQ (R2 change = 0.09. F1,30 = 3.73, p = 0.06; partial r = 0.33) at marginally 
significant levels but were not associated with scores on the reward expectancy subscale of the GRAPES 
(R2 change = 0.01. F1,30 = 0.30, p = 0.59 ) or reward-related TCI-R scales (R2 change = 0.02. F1,30 = 0.78, 
p = 0.38). Midbrain D2R BPND was not associated with Eating Related to Reward (R2 change = 0.00. 
F1,31 = 0.01, p = 0.93) or Punishment (R2 change = 0.00. F1,3 = 0.05, p = 0.83) domain scores.
Figure 3. Although the obese group self-reported lower rates of non-food reward behavior relative to 
the normal-weight group, higher BMI was associated with higher rates of non-food reward behavior 
within obese individuals. a, BMI and non-food reward behavior, a composite measure of reward-related 
behavior including approach, expectancy and sensitivity towards reward stimuli other than food, was not 
significantly associated with BMI in the normal-weight group. b, Across obese individuals, there was a 
positive relationship between BMI and non-food reward behavior. BMI, body mass index.
Figure 4. Self-reported emotional eating correlates with striatal D2R binding independent of BMI 
across normal-weight (clear circles) and obese (filled circles) individuals. Higher rates of emotion-
based eating, a composite measure of self-reported tendency to eat to avoid negative emotion, was related 
to higher a, dorsal and b, ventral striatal D2R across normal-weight and obese groups. Data points are 
standardized residuals of partial correlations after controlling for age, ethnicity, education level, and BMI. 
BPND, dopamine D2 receptor binding potential.
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Voxel-based Analysis. While positive BPND-behavioral relationships appeared to be present in stria-
tum and midbrain at less stringent criterion for statistical significance, there were no significant relation-
ships observed between D2R binding and BMI or any of the behavioral domain scores at the voxel-wise 
level (p > 0.001 for all tests).
Discussion
Our current findings contribute to the obesity and neuroimaging literature in several important ways. 
First, we characterize four different types of putatively DA-related behavior in rigorously screened, mod-
erately obese and normal-weight participants using well-validated and reliable questionnaires. To our 
knowledge, no other study has investigated these behaviors simultaneously in obese and normal-weight 
individuals to the same extent. Second, our D2R binding measurements are not confounded by D3R 
binding and competition with endogenous DA because we used the relatively novel radioligand [11C]
NMB, which is unique due to its high affinity and selectivity for D2R that appears impervious to endog-
enous DA. These radioligand properties permit us to quantify D2R specific binding levels rather than 
D2/D3R availability and avoid the influence of endogenous DA levels. Finally, we detected relation-
ships between D2R binding and behavioral phenotypes, as measured by several validated and reliable 
self-report questionnaires. These relationships were specific to two of four behavioral domains we inves-
tigated and were independent of BMI. Moreover, BMI itself did not correlate with D2R specific binding. 
These data underscore the complex interaction among eating- and reward-related behavior, BMI, and 
measures of a key central reward system (striatal and midbrain D2R specific binding). Our findings that 
eating- and reward-related behavior linearly relate to striatal and midbrain D2R, respectively, support the 
notion that regulation of food intake and reward-driven behavior involve a central reward, motor, and 
habit formation system, even though D2R specific binding was not associated with BMI.
With our ROI-based analyses, we demonstrate that obesity-associated behavior, specifically 
self-reported higher rates of eating to avoid negative emotion, correlates with higher striatal D2R bind-
ing in vivo across obese and normal-weight participants, independent of BMI. This finding is consistent 
with the recent report that striatal D2/D3R availability is positively associated with a dimension of the 
Three-factor Eating Questionnaire, ‘opportunistic eating’9, which reflects habitual, emotional, and situa-
tional susceptibility to disinhibited eating36. Our finding is consistent with theirs, but extends the results 
by using several validated questionnaires related to emotional eating and a D2-selective radioligand. 
Our results are also in line with those of a study that showed multi-locus genetic profile scores reflect-
ing enhanced DA function (including the ANKK single nucleotide polymorphism associated with D2R 
levels) relate to more emotional and binge eating37. Our findings differ from Volkow et al.38 in which 
greater emotionality was associated with lower dorsal striatal D2/D3 receptor availability. However, only 
nonobese participants were studied by Volkow et al.38 and screening criteria and the properties of the 
PET radioligand used were different than those in our study. Although not statistically significant, higher 
Figure 5. Midbrain D2R binding correlates with self-reported reward-related and eating behavior 
independent of BMI across normal-weight (clear circles) and obese (filled circles) individuals. a, 
Higher rates of non-food reward behavior, b composite measure of self-reported tendency to approach, 
anticipate, and/or be sensitive to rewarding stimuli other than food, was related to higher midbrain D2R 
across normal-weight and obese groups. a, Similar to striatal D2R binding, midbrain D2R binding positively 
related to self-reported emotional eating. Data points are standardized residuals of partial correlations after 
controlling for age, ethnicity, education level, and BMI. BPND, dopamine D2 receptor binding potential.
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dorsal striatal D2R binding in our sample tended to relate to higher BMI across normal-weight and 
moderately obese individuals, similar to Dunn et al.8. Perhaps, as others propose1,6,7, striatal DA system 
overactivity induced by repeated emotional overeating in less severe forms of overweight or obesity 
eventually downregulates striatal D2/D3R, presenting as lower receptor availability in extremely obese 
individuals as in Wang et al.4 and de Weijer et al2. Alternatively, obese individuals with relatively higher 
striatal D2R binding may be protected from developing more severe forms of obesity. Unfortunately, 
scanner weight-limits and size of the bore precluded inclusion of severely or morbidly obese individuals 
in the current study. Future investigations should employ longitudinal and/or cross-sectional studies 
to determine whether striatal D2R and obesity-associated behaviors change in accordance with large 
changes in BMI (i.e. from moderate to severe obesity).
Our ROI-based analyses also showed that midbrain D2R binding related to self-reported emotional eat-
ing and non-food reward-related behavior in a positive manner across normal-weight and obese groups. 
This is not surprising given the midbrain’s roles in motivation, habit formation39, and activity geared 
towards obtaining reward40. Our results are in apparent contrast with those of Savage et al.19, in which 
a negative relationship between novelty-seeking and substantia nigra D2/D3R availability, as measured 
by [18F]fallypride, was observed in normal-weight but not obese individuals. However novelty-seeking 
was not specifically addressed in our study – it comprised one subscale of the TCI-R questionnaire. In 
addition, unlike the D2R-selective [11C]NMB, [18F]fallypride binds to both D2R and D3R and is sensi-
tive to competition with endogenous DA41. Our results are in agreement with those of a previous study 
in which higher trait motivation related to higher midbrain and ventral striatal D2/D3R availability 
as measured by [11C]raclopride42. In our study, the relationship between midbrain D2R and non-food 
reward-related behavior appears to be driven by scores on the BAS27 and the SPSRQ30, which are meant 
to reflect responsivity to and drive for reward and reward sensitivity, respectively. In contrast to striatal 
D2R, midbrain D2R are thought to be almost exclusively located presynaptically and, when activated 
by DA transmission arising locally and from afferent projections, function as inhibitory receptors on 
cell bodies and dendrites of dopaminergic neurons, resulting in decreased DA release in midbrain and 
striatum43–46. Therefore, the midbrain may modulate DA transmission in mesostriatal reward circuitry 
through this negative feedback loop45. Since we observed positive correlations between behavior and 
D2R in both striatal and midbrain regions independent of BMI, our data indicate that D2R levels within 
this reward pathway may reflect degree of motivation for or sensitivity to obtaining non-food reward and 
alleviating negative emotions via eating in normal-weight and obese individuals. However, our findings 
should be interpreted with caution since they are correlational and future studies may experimentally 
test this hypothesis and alternative explanations.
Our moderately obese participants self-reported higher rates of emotion- and reward-based eating 
behavior but less non-food reward behavior relative to normal-weight individuals. Obese individuals 
also tended to self-report sensitivity to punishment to a greater extent than normal-weight individuals. 
Other studies also show higher rates of eating due to emotional distress in obesity7,47–50 as well as positive 
correlations between food-related reward behavior and BMI26,51–53. However, our results contrast with a 
previous study that showed an inverse relationship between BMI and non-food reward behavior in obese 
people54. Although our obese group reported lower rates of non-food reward behavior relative to the 
normal-weight group, BMI was still positively related to non-food reward behavior within obese partic-
ipants. One possible explanation for our finding is that while moderately obese individuals self-report 
reduced non-food reward-based behavior relative to normal-weight participants, there remains a gradi-
ent in which both food and non-food reward sensitivity is greater in obese individuals with higher BMI. 
Alternatively, there may be reward-insensitive and reward-sensitive subtypes of moderate obesity. Finally, 
few studies have evaluated punishment-related behavior in obesity but Franken and Muris55 found no 
significant correlation between sensitivity to punishment and food craving in participants ranging from 
underweight to obese while another study demonstrated lower behavioral inhibition in obese individ-
uals7. Taken together, our behavioral findings support the idea that obese individuals may experience 
‘reward deficiency syndrome’56, in which over-consumption of food may compensate for reduced ability 
to experience pleasure from other activities. Alternatively, RDS in obesity may be secondary to stronger 
hedonic response to food in individuals with enhanced striatal DA function37, putting them at risk of 
overeating and eventually overriding desire for other rewarding stimuli. Longitudinal investigation of 
the effect of intervention-induced changes in BMI on reward-related behavior will help clarify this rela-
tionship.
There are some limitations to the current study. First, we urge caution in interpreting our findings 
regarding relationships between central D2R binding and behavior because, admittedly, several hier-
archical linear regression analyses were performed without stringent multiple comparisons correction. 
However, our findings are supported by previous studies: Guo et al.9 detected a relationship of a similar 
nature between dorsal D2/D3R binding and ‘opportunistic eating’ and the midbrain is known to function 
as a modulator of motivation for food and non-food reward39–40,57. Still, due to the novel nature of our 
findings and the small sample on which they are based, these results will require replication. Further, 
we did not find any specific clusters of D2R binding within striatum or midbrain that related to eating 
or reward-based behavior. Our voxelwise analyses was likely less sensitive to these relationships due to 
variability in D2R binding at the voxelwise level; in contrast, the ROI-based analyses reduced variability 
in these measures due to use of mean binding potential across regions that were eroded to minimize 
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partial volume effects of neighboring regions known to have less D2R binding. Second, our results cannot 
explain whether emotional eating or non-food reward behavior precedes higher central D2R binding or 
vice versa, a key question in terms of understanding, preventing, or treating obesity. Also, due to time 
constraints, we did not control for whether participants were fasted or sated while completing relevant 
questionnaires and computer tasks. While this is an important factor to control for in the future, we can-
not know how hunger state may have affected our results here since we did not ask participants to rate 
satiety. In regards to the PET scan, [11C]NMB is not displaceable by endogenous DA and therefore D2R 
binding potential should not be impacted by satiety state. Finally, this study was designed to obtain base-
line striatal D2R binding in normal-weight and obese individuals unconfounded by health conditions 
and medications that interact with or affect DA signaling. Consequently, our results do not generalize 
to normal-weight or obese individuals with clinical diagnosis-level mental disorders thought to underlie 
some types of eating behaviors that may involve DA signaling including depression, impulsivity, binge 
eating and substance abuse. Effects of the interactions between obesity and these disorders on central 
D2R are highly important and merit further investigation. Despite these limitations, our results offer a 
template for testable hypotheses that address the limitations described.
In summary, relative to the normal-weight group, the obese group self-reported lower rates of non-food 
reward behavior and higher rates of eating behavior related to negative affect, sensitivity to rewarding 
properties of palatable foods, and sensitivity to punishment. Self-reported emotional eating positively 
correlated with striatal and midrain D2R binding across normal-weight and obese individuals. Higher 
rates of self-reported non-food reward-related behavior were associated with higher midbrain D2R bind-
ing. Taken together, our findings indicate that there are fundamental differences in self-reported eating 
and reward-related behavior between normal-weight and obese individuals and that, across both groups 
of individuals, D2R binding levels in the mesostriatal DA system may reflect degree of motivation to alle-
viate negative emotion through eating and for obtainment of non-food reward. Longitudinal investiga-
tions of how these variables interact and contribute to excessive body weight will help identify potential 
pharmacological and behavioral targets for prevention and/or treatment of obesity.
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